| 1 |
N6-methyladenosine
(3005 times)
|
Neoplasms
(486 times)
|
METTL3 (228 times)
FTO (158 times)
lncRNAs (126 times)
|
1976 5'-Terminal and internal methylated nucleotide sequences in HeLa cell mRNA.
|
| 2 |
N6-methylation of adenosine
(31 times)
|
Neoplasms
(8 times)
|
CRC (2 times)
GSEA (2 times)
lncRNA (2 times)
|
2015 N6-adenosine methylation in MiRNAs.
|
| 3 |
modification, N6-methyladenosine
(30 times)
|
Cell Biology
(5 times)
|
m5C (3 times)
KO (2 times)
LASSO (2 times)
|
2017 Detecting N6-methyladenosine sites from RNA transcriptomes using ensemble Support Vector Machines.
|
| 4 |
Methylation at the N6 position of adenosine
(17 times)
|
Virology
(3 times)
|
HA (2 times)
CLIP (1 time)
COVID-19 (1 time)
|
2017 Viral Epitranscriptomics.
|
| 5 |
methylation of adenosine at the N6-position
(6 times)
|
Genomics
(1 time)
|
SAM (2 times)
m1A (1 time)
METTL (1 time)
|
2019 m6A-mRNA methylation regulates cardiac gene expression and cellular growth.
|
| 6 |
METTL14, as one of N6-methyladenosine
(4 times)
|
Cell Biology
(2 times)
|
ALL (1 time)
ccRCC (1 time)
CIs (1 time)
|
2018 METTL3-mediated N6-methyladenosine mRNA modification enhances long-term memory consolidation.
|
| 7 |
modification in eukaryotic cells, N6-methyladenosine
(4 times)
|
Virology
(1 time)
|
circRNAs (1 time)
KSHV (1 time)
SV40 (1 time)
|
2018 The RNA Epitranscriptome of DNA Viruses.
|
| 8 |
N6-methylated adenine
(4 times)
|
Biochemistry
(2 times)
|
N6-mAMP (1 time)
|
2018 m6A RNA Degradation Products Are Catabolized by an Evolutionarily Conserved N6-Methyl-AMP Deaminase in Plant and Mammalian Cells.
|
| 9 |
methyl groups at the N6 position
(3 times)
|
Biological Science Disciplines
(1 time)
|
8-NO2-G (1 time)
CTD (1 time)
m5C (1 time)
|
2018 Addition of m6A to SV40 late mRNAs enhances viral structural gene expression and replication.
|
| 10 |
methyltransferase which catalyze N6-methyladenosine
(3 times)
|
Cell Biology
(3 times)
|
ADPKD (1 time)
DUBs (1 time)
NRCMs (1 time)
|
2021 A methionine-Mettl3-N6-methyladenosine axis promotes polycystic kidney disease.
|
| 11 |
mRNA and noncoding RNAs is N6-methyladenosine
(3 times)
|
Neoplasms
(1 time)
|
FTO (1 time)
GBM (1 time)
GC (1 time)
|
2019 Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
|
| 12 |
m62A and N6-methyladenine
(2 times)
|
Bacteriology
(1 time)
|
m1A (1 time)
m2G (1 time)
m6G (1 time)
|
1979 23S ribosomal ribonucleic acid of macrolide-producing streptomycetes contains methylated adenine.
|
| 13 |
markers and prognostic performance of N6-methyladenosine
(2 times)
|
Biomedical Research
(1 time)
|
CM (1 time)
CNV (1 time)
GTEx (1 time)
|
2021 Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma.
|
| 14 |
mechanisms, and N6-methyladenosine
(2 times)
|
Genetics
(1 time)
|
ABHD11-AS1 (1 time)
IDD (1 time)
lncRNA (1 time)
|
2020 Bioinformatics analysis integrating metabolomics of m6A RNA microarray in intervertebral disc degeneration.
|
| 15 |
methyl-6-adenosine
(2 times)
|
Molecular Biology
(1 time)
|
5mC (1 time)
LINE (1 time)
m5C (1 time)
|
2017 Illustrating the Epitranscriptome at Nucleotide Resolution Using Methylation-iCLIP (miCLIP).
|
| 16 |
methylate and demethylate N6-methyladenosine
(2 times)
|
Biochemistry
(1 time)
|
m6ACE-seq (1 time)
XIST (1 time)
|
2019 Atlas of quantitativesingle-base-resolution N6-methyl-adenine methylomes.
|
| 17 |
Methylation of the adenosine base at the nitrogen-6 position
(2 times)
|
Molecular Biology
(2 times)
|
ABEs (1 time)
SNP (1 time)
|
2017 Most m6A RNA Modifications in Protein-Coding Regions Are Evolutionarily Unconserved and Likely Nonfunctional.
|
| 18 |
microbiota and N6-methyladenosine
(2 times)
|
Immune System Diseases
(1 time)
|
TIICs (2 times)
TME (2 times)
BLCA (1 time)
|
2021 Interferon-Induced Transmembrane Protein 3 Shapes an Inflamed Tumor Microenvironment and Identifies Immuno-Hot Tumors.
|
| 19 |
modified nucleotides are N6-methyladenosine
(2 times)
|
Cell Biology
(2 times)
|
m6Am (1 time)
TSSs (1 time)
|
2019 Identification of the m6Am Methyltransferase PCIF1 Reveals the Location and Functions of m6Am in the Transcriptome.
|
| 20 |
molecules, and N6-methyladenosine
(2 times)
|
Neoplasms
(2 times)
|
DEFRlncRNAs (1 time)
FRGs (1 time)
FRlncRNAs (1 time)
|
2022 Construction of a Prognostic Model for KIRC and Identification of Drugs Sensitive to Therapies - A Comprehensive Biological Analysis Based on m6A-Related LncRNAs.
|
| 21 |
most abundant mRNA modification, N6-methyladenosine
(2 times)
|
Medical Informatics
(1 time)
|
m6A-reg-exp (1 time)
Tg (1 time)
|
2019 Epitranscriptomics: Correlation of N6-methyladenosine RNA methylation and pathway dysregulation in the hippocampus of HIV transgenic rats.
|
| 22 |
mRNA and lncRNA, N6-methyladenosine
(2 times)
|
Biochemistry
(2 times)
|
m1A (1 time)
|
2022 m6A-TSHub: Unveiling the Context-specific m6A Methylation and m6A-affecting Mutations in 23 Human Tissues.
|
| 23 |
6-methylaminopurine
(1 time)
|
Biochemistry
(1 time)
|
m5C (1 time)
|
2005 The language of methylation in genomics of eukaryotes.
|
| 24 |
ARSTRACTN6-methyladenosine
(1 time)
|
Bioengineering
(1 time)
|
FTO (1 time)
KLF3 (1 time)
OS (1 time)
|
2022 Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Kruppel-like factor 3 (KLF3) promotes osteosarcoma progression.
|
| 25 |
foundN6-methyladenosine
(1 time)
|
Biotechnology
(1 time)
|
---
|
2022 m6A-mediated modulation coupled with transcriptional regulation shapes long noncoding RNA repertoire of the cGAS-STING signaling.
|
| 26 |
hemi-methylated, and fully methylated N6-methyladenine
(1 time)
|
Biochemistry
(1 time)
|
m5C (1 time)
|
1990 Analysis of substrate specificity of the PaeR7 endonuclease: effect of base methylation on the kinetics of cleavage.
|
| 27 |
kit-8,N6-methyladenosine
(1 time)
|
Medicine
(1 time)
|
AML (1 time)
METTL3 (1 time)
|
2018 [Methyltransferase-like 3 Promotes the Proliferation of Acute Myeloid Leukemia Cells by Regulating N6-methyladenosine Levels of MYC].
|
| 28 |
M2 activation by targeting tuberous sclerosis 1 via an N6-methyladenosine
(1 time)
|
Biomedical Research
(1 time)
|
IL-4 (1 time)
mRNA (1 time)
STAT6 (1 time)
|
2021 The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARgamma.
|
| 29 |
m6A in immune response and explore N6-methyladenosine
(1 time)
|
Neoplasms
(1 time)
|
ccRCC (1 time)
|
2022 N6-methyladenosine methylation related immune biomarkers correlates with clinicopathological characteristics and prognosis in clear cell renal cell carcinoma.
|
| 30 |
m6A level via recruiting N6-methyladenosine
(1 time)
|
Cell Biology
(1 time)
|
HCC (1 time)
ILF3-AS1 (1 time)
lncRNA (1 time)
|
2021 Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m6A-dependent manner.
|
| 31 |
m6A sequencing, which confirmed that altered N6-methyladenosine
(1 time)
|
Environmental Health
(1 time)
|
COPD (1 time)
Cyth1 (1 time)
EMPs (1 time)
|
2022 PM2.5 induces pulmonary microvascular injury in COPD via METTL16-mediated m6A modification.
|
| 32 |
m6A, and methylated
(1 time)
|
Cardiology
(1 time)
|
FTO (1 time)
|
2018 FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.
|
| 33 |
m6A-Atlas: a comprehensive knowledgebase for unraveling the N6-methyladenosine
(1 time)
|
Biochemistry
(1 time)
|
---
|
2020 m6A-Atlas: a comprehensive knowledgebase for unraveling the N6-methyladenosine (m6A) epitranscriptome.
|
| 34 |
m6Am and 5'-UTR N6-methyladenosine
(1 time)
|
Biology
(1 time)
|
---
|
2021 m6Am-seq reveals the dynamic m6Am methylation in the human transcriptome.
|
| 35 |
m6Am rather than N6-methyladenosine
(1 time)
|
Science
(1 time)
|
FTO (1 time)
|
2016 Reversible methylation of m6Am in the 5' cap controls mRNA stability.
|
| 36 |
major RNA N6-adenosine methyltransferase
(1 time)
|
Biology
(1 time)
|
CNAB (1 time)
iCCA (1 time)
pCCA (1 time)
|
2022 The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers.
|
| 37 |
mammalian messenger RNA, N6methyladenosine
(1 time)
|
Gynecology
(1 time)
|
EMT (1 time)
|
2018 METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition.
|
| 38 |
mark N 6-methyladenine
(1 time)
|
Plant Physiological Phenomena
(1 time)
|
ABA (1 time)
|
2021 ALKBH10B, an mRNA m6A Demethylase, Modulates ABA Response During Seed Germination in Arabidopsis.
|
| 39 |
Mechanism and Role of N6-Methyladenosine
(1 time)
|
Cardiovascular System
(1 time)
|
AD (1 time)
AS (1 time)
|
2022 The Mechanism and Role of N6-Methyladenosine (m6A) Modification in Atherosclerosis and Atherosclerotic Diseases.
|
| 40 |
mechanism by which N 6 -methyladenosine
(1 time)
|
Genetic Phenomena
(1 time)
|
FAK (1 time)
LASSO (1 time)
lncRNAs (1 time)
|
2022 N 6 -Methyladenosine-Related Long Non-Coding RNAs Are Identified as a Potential Prognostic Biomarker for Lung Squamous Cell Carcinoma and Validated by Real-Time PCR.
|
| 41 |
mechanism of the RNA N6,2'-O-dimethyladenosine
(1 time)
|
Hematology
(1 time)
|
METTL3 (1 time)
RIP (1 time)
UBXN1 (1 time)
|
2021 YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.
|
| 42 |
Mechanistically, FEZF1AS1 expression was influenced by N6methyladenosine
(1 time)
|
Neoplasms
(1 time)
|
lncRNAs (1 time)
miR (1 time)
NSCLC (1 time)
|
2020 Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis.
|
| 43 |
messenger RNA, such as N6-methyladenosine
(1 time)
|
Genetics, Medical
(1 time)
|
---
|
2020 N6-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2.
|
| 44 |
messenger RNAs identified, N6-methyladenosine
(1 time)
|
Genetics
(1 time)
|
---
|
2017 Role of N6-methyladenosine modification in cancer.
|
| 45 |
metabolism were explored.N6-methyladenosine
(1 time)
|
Cell Biology
(1 time)
|
DMM (1 time)
ECM (1 time)
EVs (1 time)
|
2022 Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage.
|
| 46 |
methylated at internal adenosine residues to form N6-methyladenosine
(1 time)
|
Cell Biology
(1 time)
|
---
|
1987 Unequal distribution of N6-methyladenosine in influenza virus mRNAs.
|
| 47 |
methylated at the N6 position of A to form N6-methyladenine
(1 time)
|
|
8-oxo-dGTP (1 time)
8-oxodG (1 time)
HG (1 time)
|
2018 The m6A methylation perturbs the Hoogsteen pairing-guided incorporation of an oxidized nucleotide.
|
| 48 |
methylation and post-transcriptionally by N-6-methyladenosine
(1 time)
|
Genetics
(1 time)
|
FA (1 time)
|
2020 Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells.
|
| 49 |
methylation at position N6 in adenosine
(1 time)
|
Neoplasms
(1 time)
|
lncRNAs (1 time)
mCRPC (1 time)
MTC (1 time)
|
2020 VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer.
|
| 50 |
methylation at position N6 of adenine is called N6-methyladenosine
(1 time)
|
Genetic Phenomena
(1 time)
|
DFI (1 time)
DSS (1 time)
GO (1 time)
|
2021 Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
|
| 51 |
methylation of messenger RNA at the N6 position
(1 time)
|
Cell Biology
(1 time)
|
---
|
2020 Dm Ime4 depletion affects permeability barrier and Chic function in Drosophila spermatogenesis.
|
| 52 |
methylations of adenosine to form either N 6-methyladenosine
(1 time)
|
Biology
(1 time)
|
m6Am (1 time)
mRNA (1 time)
|
2019 Discovering and Mapping the Modified Nucleotides That Comprise the Epitranscriptome of mRNA.
|
| 53 |
METTL14 and N6-adenosine methylation
(1 time)
|
Chemistry
(1 time)
|
HDAC (1 time)
mESCs (1 time)
TSA (1 time)
|
2020 The Distinct Function and Localization of METTL3/METTL14 and METTL16 Enzymes in Cardiomyocytes.
|
| 54 |
METTL14 dimerize to form an N6-methyladenosine
(1 time)
|
Stem Cells
(1 time)
|
ESC (1 time)
METTL (1 time)
|
2022 METTLing in Stem Cell and Cancer Biology.
|
| 55 |
METTL14, a critical component of N6-methyladenosine
(1 time)
|
Neoplasms
(1 time)
|
---
|
2021 METTL14 gene polymorphisms decrease Wilms tumor susceptibility in Chinese children.
|
| 56 |
METTL3 and METTL14-mediated N6-methyladenosine
(1 time)
|
Reproductive Medicine
(1 time)
|
---
|
2022 METTL3 and METTL14-mediated N6-methyladenosine modification promotes cell proliferation and invasion in a model of endometriosis.
|
| 57 |
METTL3, an enzyme catalyzes the formation of N6-methyladenosine
(1 time)
|
Biochemistry
(1 time)
|
ECM (1 time)
OA (1 time)
|
2019 METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.
|
| 58 |
miR-1299 and ZC3H13/N6-methyladenosine
(1 time)
|
Biochemistry
(1 time)
|
circRNAs (1 time)
HCC (1 time)
|
2022 circRERE regulates the expression of GBX2 through miR-1299 and ZC3H13/N6-methyladenosine (m6A) to promote growth and invasion of hepatocellular carcinoma cells.
|
| 59 |
miR181d5p by the RNA N6methyladenosine
(1 time)
|
Neoplasms
(1 time)
|
CAFs (1 time)
CRC (1 time)
DGCR8 (1 time)
|
2022 N6‑methyladenosine upregulates miR‑181d‑5p in exosomes derived from cancer‑associated fibroblasts to inhibit 5‑FU sensitivity by targeting NCALD in colorectal cancer.
|
| 60 |
modification and regulation of N6-methyladenosine
(1 time)
|
Translational Medical Research
(1 time)
|
RCC (1 time)
RIP (1 time)
|
2020 ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner.
|
| 61 |
modification, N6-adenosine methylation
(1 time)
|
Immune System Diseases
(1 time)
|
METTL3 (1 time)
SOCS3 (1 time)
TP (1 time)
|
2022 YTHDF1 Negatively Regulates Treponema pallidum-Induced Inflammation in THP-1 Macrophages by Promoting SOCS3 Translation in an m6A-Dependent Manner.
|
| 62 |
modifications after transcription, such as N6-methyladenosine
(1 time)
|
Gastroenterology
(1 time)
|
---
|
2020 Epitranscriptomics in liver disease: Basic concepts and therapeutic potential.
|
| 63 |
modifications and, in particular, for N6-methyladenosine
(1 time)
|
Medical Informatics
(1 time)
|
MeRIP-seq (1 time)
MoAIMS (1 time)
|
2020 MoAIMS: efficient software for detection of enriched regions of MeRIP-Seq.
|
| 64 |
modifications are common in pharmacogenes, especially N6-methyladenosine
(1 time)
|
Nucleic Acids
(1 time)
|
AML (1 time)
TNBC (1 time)
|
2022 Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatment.
|
| 65 |
modifications are known, such as 6-methyladenosine
(1 time)
|
|
AML (1 time)
HSPCs (1 time)
m5C (1 time)
|
2021 Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia.
|
| 66 |
modifications of DNA and RNA, with particular focus on N6-methyladenosine
(1 time)
|
Neoplasms
(1 time)
|
HDACs (1 time)
MAR (1 time)
|
2020 Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs.
|
| 67 |
modifications of RNA, such as N1methyladenosine, 2'Oribosemethylation, inosine, 5methylcytidine, N6methyladenosine
(1 time)
|
Neoplasms
(1 time)
|
AML (1 time)
circRNAs (1 time)
|
2021 Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review).
|
| 68 |
Modifications Revealed Increased Levels of N 6-Methyladenosine
(1 time)
|
|
m1A (1 time)
ROC (1 time)
|
2021 Quantitative Analysis of Methylated Adenosine Modifications Revealed Increased Levels of N 6-Methyladenosine (m6A) and N 6,2'-O-Dimethyladenosine (m6Am) in Serum From Colorectal Cancer and Gastric Cancer Patients.
|
| 69 |
modulated by the writer, eraser, and reader proteins of N6-methyladenosine
(1 time)
|
Biology
(1 time)
|
---
|
2019 HSP90 inhibitors stimulate DNAJB4 protein expression through a mechanism involving N6-methyladenosine.
|
| 70 |
monomethylating the N6-atom of adenine
(1 time)
|
Molecular Biology
(1 time)
|
MTases (1 time)
SAM (1 time)
|
2019 Bisubstrate analogues as structural tools to investigate m6A methyltransferase active sites.
|
| 71 |
morbidity and mortality. n6-methyladenosine
(1 time)
|
Immune System Diseases
(1 time)
|
CNV (1 time)
ESCA (1 time)
qRT-PCR (1 time)
|
2022 Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
|
| 72 |
Moreover, ALKBH5-mediated N6-methyladenosine
(1 time)
|
Cell Death
(1 time)
|
CUL4A (1 time)
HCC (1 time)
lncRNAs (1 time)
|
2022 LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2.
|
| 73 |
Moreover,N6-methyladenosine
(1 time)
|
Neoplasms
(1 time)
|
lncRNAs (1 time)
METTL3 (1 time)
TNBC (1 time)
|
2022 WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis.
|
| 74 |
most abundant among them is N6-methyladenosine
(1 time)
|
Biological Science Disciplines
(1 time)
|
YTHDF3 (1 time)
|
2018 Dynamic m6A methylation facilitates mRNA triaging to stress granules.
|
| 75 |
most abundant, and encompasses N6-methyladenosine
(1 time)
|
Genetic Phenomena
(1 time)
|
m5C (1 time)
m7G (1 time)
|
2022 An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
|
| 76 |
most common of which is the N6methyladenosine
(1 time)
|
Genes, Regulator
(1 time)
|
---
|
2018 The m6A‑methylase complex and mRNA export.
|
| 77 |
mRNA and protein expression in an N6-methyladenosine
(1 time)
|
Hematologic Diseases
(1 time)
|
ALKBH5 (1 time)
PAQR4 (1 time)
|
2023 ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner.
|
| 78 |
mRNA and suppressed its stability through interaction with the N6-methyladenosine
(1 time)
|
Biochemistry
(1 time)
|
GC (1 time)
lncRNA (1 time)
|
2019 LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells.
|
| 79 |
mRNA in eukaryotes is N6-methyladenosine
(1 time)
|
Biology
(1 time)
|
IGF2BPs (1 time)
RBPs (1 time)
|
2022 The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer.
|
| 80 |
mRNA in higher eukaryotes, N6-methyladenosine
(1 time)
|
Hematology
(1 time)
|
CTCL (1 time)
|
2022 The "m6A writer" METTL3 and the "m6A reader" IGF2BP2 regulate cutaneous T-cell lymphomas progression via CDKN2A.
|
| 81 |
mRNA- and RNA-binding protein composition by regulating N6-methyladenosine
(1 time)
|
Antioxidants
(1 time)
|
LLPS (1 time)
MLOs (1 time)
PTMs (1 time)
|
2021 Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders.
|
| 82 |
mRNAs, N6-adenosine methylation
(1 time)
|
Genes, Regulator
(1 time)
|
---
|
2018 The role of RNA adenosine demethylases in the control of gene expression.
|
| 83 |
multi-omics data, including immune characteristics, N 6-methyladenosine
(1 time)
|
Genetic Phenomena
(1 time)
|
GInLncRNAs (1 time)
GInLncSig (1 time)
GSEA (1 time)
|
2022 Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma.
|
| 84 |
multiple N6methyladenosine
(1 time)
|
Neoplasms
(1 time)
|
EC (1 time)
|
2022 RNA m6A methylation regulators in endometrial cancer (Review).
|
| 85 |
N4-methylcytosine and N6-methyladenine
(1 time)
|
Biochemistry
(1 time)
|
---
|
2006 Undetectable levels of N6-methyl adenine in mouse DNA: Cloning and analysis of PRED28, a gene coding for a putative mammalian DNA adenine methyltransferase.
|
| 86 |
N6-methyl-A
(1 time)
|
Biochemistry
(1 time)
|
m7G (2 times)
m1G (1 time)
m5C (1 time)
|
1984 Antibody-nucleic acid complexes. Antigenic domains within nucleosides as defined by solid-phase immunoassay.
|
| 87 |
N6-methylandrostenedione
(1 time)
|
|
GEO (1 time)
STAD (1 time)
|
2022 Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma.
|
| 88 |
N6-methylation found on adenosine
(1 time)
|
Biochemistry
(1 time)
|
MTases (1 time)
|
2021 A comprehensive review of m6A/m6Am RNA methyltransferase structures.
|
| 89 |
N6-methylation of internal adenosines
(1 time)
|
Science
(1 time)
|
Ck1delta (1 time)
|
2018 Two Ck1delta transcripts regulated by m6A methylation code for two antagonistic kinases in the control of the circadian clock.
|
| 90 |
N6-methyldeoxyadenine
(1 time)
|
Molecular Biology
(1 time)
|
m5C (1 time)
MTases (1 time)
|
1997 Chlorella virus SC-1A encodes at least five functional and one nonfunctional DNA methyltransferases.
|
| 91 |
N6-monomethyl adenine
(1 time)
|
Bacteriology
(1 time)
|
rRNA (1 time)
|
1975 Systematic difference in the methylation of ribosomal ribonucleic acid from gram-positive and gram-negative bacteria.
|
| 92 |
Potential-N6-methyladenosine
(1 time)
|
Translational Medical Research
(1 time)
|
AUC (1 time)
GEO (1 time)
GSEA (1 time)
|
2022 Genome-wide screening and immune landscape suggest a potential-m6A-related lncRNA risk signature for predicting prognosis of melanoma.
|
| 93 |
S-adenosyl-L-methionine to N6 amino group of adenosine bases in RNA
(1 time)
|
Biological Science Disciplines
(1 time)
|
METTL3 (1 time)
ssDNA (1 time)
|
2022 RNA binding to human METTL3-METTL14 restricts N6-deoxyadenosine methylation of DNA in vitro.
|
A Search Service for Abbreviation / Long Form